Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 23, Number 12—December 2017
Dispatch

Lack of Secondary Transmission of Ebola Virus from Healthcare Worker to 238 Contacts, United Kingdom, December 2014

Paul CrookComments to Author , Alison Smith-Palmer, Helen Maguire, Noel McCarthy, Hilary Kirkbride, Bruce Court, Sanch Kanagarajah, Deborah Turbitt, Syed Ahmed, Paul Cosford, and Isabel Oliver
Author affiliations: Public Health England, London, UK (P. Crook, H. Maguire, N. McCarthy, H. Kirkbride, B. Court, S. Kanagarajah, D. Turbitt, P. Cosford, I. Oliver); Health Protection Scotland, Glasgow, Scotland, UK (A. Smith-Palmer, S. Ahmed); University College London, London (H. Maguire)

Cite This Article

Abstract

In December 2014, Ebola virus disease (EVD) was diagnosed in a healthcare worker in the United Kingdom after the worker returned from an Ebola treatment center in Sierra Leone. The worker flew on 2 flights during the early stages of disease. Follow-up of 238 contacts showed no evidence of secondary transmission of Ebola virus.

More than 28,000 cases of Ebola virus disease (EVD) were reported during the epidemic in West Africa in 2014–2015 (1). International healthcare workers (HCWs) responded, and a number subsequently became infected with EVD, including those given a diagnosis after their return travel (2). There is international guidance for follow-up of aircraft contacts of case-patients with EVD (35).

We report contact tracing after EVD was diagnosed in an HCW in the United Kingdom who had worked in an Ebola treatment center in Sierra Leone. This worker had become ill while traveling back to the United Kingdom via Morocco.

The Study

For this investigation, a multiagency incident control team and contact tracing teams were established with staff of Public Health England (PHE) and Health Protection Scotland. We undertook a risk assessment that included interviewing the case-patient about symptoms, travel, and contacts. We used preexisting guidance (6) to classify contacts according to their degree of exposure to the case-patient and to other persons with EVD on the basis of the degree of infectiousness and physical contact (Table). The degree of public health follow-up of contacts was formulated according to their exposure category (Table).

We asked airlines to provide passenger manifests; advanced passenger information (nationality, passport numbers, date of birth); and contact details. If contact details were missing or incorrect, we sought additional information from Her Majesty’s Passport Office, the UK Border Agency, PHE port entry screening and returning workers information, the National Health Service Patient Demographic Service, and online social networks. For contacts with UK addresses, we conducted a home visit if telephone contact was unsuccessful. For foreign national contacts, PHE also contacted the National Focal Point of the relevant country as per International Health Regulations. Public helplines were established to provide a contact point for those potentially affected. PHE provided public health advice to United Kingdom airline staff, and Moroccan authorities provided public health advice to Morocco airline staff. Moroccan authorities led contact tracing for the flight to Morocco, which is not reported in this article.

The case-patient was a UK national HCW who had worked in an Ebola treatment center in Sierra Leone and had direct patient contact. On December 28, 2014, she flew from Sierra Leone to Glasgow on 3 flights and 2 aircraft of 2 airlines: from Freetown, Sierra Leone, to Casablanca, Morocco (3 h, 40 min); Casablanca to London, England (3 h, 30 min); and London to Glasgow, Scotland (1 h, 20 min).

During exit screening before boarding in Freetown and Casablanca, the case-patient was reported to have been apyrexial. Symptoms of fever and malaise began during the Casablanca to London flight. At London Heathrow Airport, several readings of temperatures <37.6°C were made by screening staff before onward travel. In Glasgow, after the case-patient took a taxi home, her symptoms worsened, and she telephoned local health services. The case-patient did not report vomiting, diarrhea, or bleeding before diagnosis and admission. Contacts had not been exposed to body fluids.

The case-patient was admitted to a hospital in Glasgow and given a diagnosis of EVD on December 29, 2014. The patient was subsequently transferred by military plane to a specialist infectious diseases hospital in London on December 30, 2014. She survived her illness.

Aircraft passengers in the same seat row and 2 rows in front of and behind the case-patient were classified as category 2 contacts. All other passengers and crew were classified as category 1 contacts. Border Force staff, health screeners, and HCWs were classified as a category 1 contacts, and a community contact was classified as category 2 contact (Table).

A total of 238 persons, including 185 category 1 contacts and 24 category 2 contacts, were assessed as having sufficient exposure to the case-patient to warrant further public health follow-up (Table). Although no contacts were classified as being category 3 (direct contact with high exposure risk) because of exposure to the case-patient, 29 contacts were classified as category 3 because of other Ebola exposures, including healthcare work in Sierra Leone.

All 16 non–flight-related contacts were successfully followed up. Passengers on the Casablanca to London flight represented 17 nationalities, and 59 (45%) of 132 had non-UK passports. We successfully contacted all passengers on both flights, except for 3 category 1 passengers who had non-UK passports (199/202, 99%); a total of 162 (80%) passengers were contacted within 48 h of diagnosis for the case-patient.

We provided information for the 3 passengers we could not contact to their respective countries through their National Focal Point. Two persons in the United Kingdom required home visits. All flight crew were contacted. No additional cases of EVD were identified among contacts.

Conclusions

We report no evidence of secondary transmission of Ebola virus to contacts of a case-patient who contracted EVD during the Ebola epidemic in West Africa in 2014–2015 and who was given a diagnosis in the United Kingdom. There have been few reports of symptomatic EVD case-patients traveling by commercial airline, and secondary transmission has not been documented (710). The case-patient we report was probably in the early stages of illness, and there was no evidence of high-risk exposure to body fluids on board the aircraft.

A precautionary approach was taken regarding contacts on the aircraft, wider than international guidance recommends (one seat in either direction of the case-patient) (35) but consistent with the response to a case diagnosed in the United States (10). The decision to contact all persons on the affected aircraft was taken to inform and reassure contacts, not just to prevent transmission.

The limited information on passengers initially available hampered the ability to make contact promptly and resulted in extensive efforts to trace persons. Furthermore, flight manifests included passengers who had not flown. Issues with flight information have arisen before in the United Kingdom related to contact tracing (11). The need for airlines to collect personal rather than agency contact details should be stressed. To ensure a rapid response, public health agencies need to work with airlines and other international organizations to ensure access to a minimum dataset that would support rapid notification of contacts. In the United Kingdom, the National Health Service Patient Demographic Service was essential for obtaining contact details and identifying whether contacts were likely to be UK residents. In addition, the Ebola port entry screening and returning workers scheme provided rapid information on 37 contacts whose journey originated in Ebola-affected countries.

Temperature screening while the case-patient transferred through Heathrow Airport did not confirm fever, and the patient was allowed to continue the journey. In the presence of exit screening, airport entry screening might not detect imported EVD (12,13). However, one purpose of this screening has been to ensure that persons receive information to enable them to seek care quickly and in a manner that helps prevent transmission. Advice provided during airport screening and healthcare deployments aims to ensure that when symptoms develop, exposed persons contact health services early and by telephone, enabling responders to take appropriate measures to reduce transmission. In this instance, early contact with health services resulted in only a small number of contacts outside the flights. An evaluation of EVD port entry screening and a scheme for returning workers in the United Kingdom is under way.

This study provides support for the conclusion that there is low risk for transmission of Ebola virus on aircraft from EVD case-patients in the early stages of disease. Providing information and advice to contacts can be a helpful public health intervention in minimizing virus transmission.

Dr. Crook is a consultant epidemiologist in the Field Epidemiology Service of Public Health England, London, UK. His research interests are outbreak response and epidemiology of sexually transmitted infections and HIV infections, including shigellosis in men who have sex with men.

Top

Acknowledgment

We thank the staff at the Royal Free London National Health Service Foundation Trust for case-patient interviewing; National Incident Control Team members, including Gina Radford and Jill Meara, and Health Protection Scotland staff; PHE Centre Health Protection teams, including Sara Atkin; PHE Field Epidemiology Service teams; the PHE Centre for Chemicals Radiation and Environmental Hazards; the PHE Centre for Infectious Disease Surveillance and Control, including Carol Chatt; the PHE International Health Regulations team, including Jane Jones, Joanne Freedman, and Gemma Smith; and Public Health Wales, including Chris Williams, for coordination and support with contact tracing; the PHE Ebola Guidance Cell for advice on contact tracing; Keith Neal for liaison with screening teams; Piers Mook for database coordination; PHE Ebola screening and returning workers, including Mark Driver and Tanya Semple, for liaison with airlines; the PHE Emergency Response Department for coordination and establishing a help line; and Moroccan and other international public health authorities for support with airline staff and passenger contact tracing.

Top

References

  1. World Health Organization. Ebola situation report, March 20, 2016 [cited 2017 Sep 14]. http://apps.who.int/ebola/current-situation/ebola-situation-report-30-march-2016
  2. Petti  S, Protano  C, Messano  GA, Scully  C. Ebola virus infection among western healthcare workers unable to recall the transmission route. Biomed Res Int. 2016;2016:8054709. Epub 2016 Nov 27. DOI
  3. Leitmeyer  K. European risk assessment guidance for infectious diseases transmitted on aircraft—the RAGIDA project. Euro Surveill. 2011;16:19845.PubMed
  4. Gilsdorf  A, Morgan  D, Leitmeyer  K. Guidance for contact tracing of cases of Lassa fever, Ebola or Marburg haemorrhagic fever on an airplane: results of a European expert consultation. BMC Public Health. 2012;12:1014. DOIPubMed
  5. World Health Organization. Travel and transport risk assessment: interim guidance for public health authorities and the transport sector, 2014 [cited 2017 Sep 14]. http://apps.who.int/iris/bitstream/10665/132168/1/WHO_EVD_Guidance_TravelTransportRisk_14.1_eng.pdf
  6. Advisory Committee on Dangerous Pathogens Public Health England. Management of hazard group 4 viral haemorrhagic fevers and similar human infectious diseases of high consequence, November 2015 [cited 2017 Sep 14]. http://www.nric.org.uk/node/54189
  7. Formenty  P, Hatz  C, Le Guenno  B, Stoll  A, Rogenmoser  P, Widmer  A. Human infection due to Ebola virus, subtype Côte d’Ivoire: clinical and biologic presentation. J Infect Dis. 1999;179(Suppl 1):S4853. DOIPubMed
  8. Shuaib  F, Gunnala  R, Musa  EO, Mahoney  FJ, Oguntimehin  O, Nguku  PM, et al.; Centers for Disease Control and Prevention (CDC). Ebola virus disease outbreak - Nigeria, July-September 2014. MMWR Morb Mortal Wkly Rep. 2014;63:86772.PubMed
  9. Fasina  FO, Shittu  A, Lazarus  D, Tomori  O, Simonsen  L, Viboud  C, et al. Transmission dynamics and control of Ebola virus disease outbreak in Nigeria, July to September 2014. Euro Surveill. 2014;19:20920. DOIPubMed
  10. Regan  JJ, Jungerman  R, Montiel  SH, Newsome  K, Objio  T, Washburn  F, et al.; Centers for Disease Control and Prevention (CDC). Public health response to commercial airline travel of a person with Ebola virus infection - United States, 2014. MMWR Morb Mortal Wkly Rep. 2015;64:636.PubMed
  11. Parry-Ford  F, Boddington  N, Pebody  R, Phin  N, on behalf of the Incident Managemen  C; Incident Management Team. Public health response to two incidents of confirmed MERS-CoV cases travelling on flights through London Heathrow Airport in 2014 – lessons learnt. Euro Surveill. 2015;20:21114. DOIPubMed
  12. Mabey  D, Flasche  S, Edmunds  WJ. Airport screening for Ebola. BMJ. 2014;349(oct14 17):g6202. DOIPubMed
  13. Cosford  P. Advantages of airport screening for Ebola. BMJ. 2014;349(nov04 4):g6585. DOIPubMed

Top

Table

Top

Cite This Article

DOI: 10.3201/eid2312.171100

Table of Contents – Volume 23, Number 12—December 2017

Comments

Please use the form below to submit correspondence to the authors or contact them at the following address:

Paul Crook, Field Epidemiology Service, Public Health England, Skipton House, 80 London Rd, London SE1 6LH, UK

Send To

character(s) remaining.

Comment submitted successfully, thank you for your feedback.

Top

Page created: March 05, 2018
Page updated: March 05, 2018
Page reviewed: March 05, 2018
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external